Tao Zhuang

Jiangsu Key Laboratory Of Marine Pharmaceutical Screening
Lianyungang, 222005, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Design and synthesis of long-acting prodrugs of SEP-363856 with sustained antipsychotic-like activity.

Design and synthesis of long-acting prodrugs of SEP-363856 with sustained antipsychotic-like activity.

Journal: Bioorganic chemistry

Published: June 16, 2026

Discovery of novel N-(alkylpiperidinyl) substituted benzamides targeting the glycine transporter 2 with anti-nociceptive effects in neuropathic pain.

Discovery of novel N-(alkylpiperidinyl) substituted benzamides targeting the glycine transporter 2 with anti-nociceptive effects in neuropathic pain.

Journal: European journal of medicinal chemistry

Published: April 10, 2026

Targeting P2X receptors for analgesia: Small molecule antagonists in development.

Targeting P2X receptors for analgesia: Small molecule antagonists in development.

Journal: European journal of medicinal chemistry

Published: April 08, 2026

Hydrogen Sulfide in Analgesia: The Journey from Gas to Hybrids and Beyond.

Hydrogen Sulfide in Analgesia: The Journey from Gas to Hybrids and Beyond.

Journal: Journal of medicinal chemistry

Published: March 30, 2026

Discovery of novel HDAC6 inhibitors based on the diphenyl-1,2,4-oxadiazole scaffold with potential efficacy in alleviating inflammation- and chemotherapy- associated mechanical hypersensitivity.

Discovery of novel HDAC6 inhibitors based on the diphenyl-1,2,4-oxadiazole scaffold with potential efficacy in alleviating inflammation- and chemotherapy- associated mechanical hypersensitivity.

Journal: Bioorganic chemistry

Published: January 15, 2026

Discovery of 3-indolealkylamines as novel dual-target σ1R/H3R ligands with potent analgesia.

Discovery of 3-indolealkylamines as novel dual-target σ1R/H3R ligands with potent analgesia.

Journal: European journal of medicinal chemistry

Published: November 04, 2025

New co-drugs of O-demethylvenlafaxine and NSAIDs exert antidepressant effects by alleviating inflammation, oxidative stress, and increasing neurotransmitter.

New co-drugs of O-demethylvenlafaxine and NSAIDs exert antidepressant effects by alleviating inflammation, oxidative stress, and increasing neurotransmitter.

Journal: International immunopharmacology

Published: October 18, 2025

A new drug-drug co-amorphous system of imipramine and celecoxib with improved solubility and synergistic antinociceptive effects.

A new drug-drug co-amorphous system of imipramine and celecoxib with improved solubility and synergistic antinociceptive effects.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: August 30, 2025

Discovery of a long-acting nanocrystal formulation of INND-2201, a new co-drug of pregabalin and palmitoylethanolamide with synergistic analgesic effects.

Discovery of a long-acting nanocrystal formulation of INND-2201, a new co-drug of pregabalin and palmitoylethanolamide with synergistic analgesic effects.

Journal: Pharmaceutical science advances

Published: July 24, 2025

Venlafaxine combined with γ-aminobutyric acid exerted improved antidepressant and anxiolytic effects through modulating neurotransmitters and neuroplasticity.

Venlafaxine combined with γ-aminobutyric acid exerted improved antidepressant and anxiolytic effects through modulating neurotransmitters and neuroplasticity.

Journal: Physiology & behavior

Published: June 16, 2025

Discovery of two new co-drugs of celecoxib and gabapentinoids for treating chemotherapy-induced peripheral neuropathy.

Discovery of two new co-drugs of celecoxib and gabapentinoids for treating chemotherapy-induced peripheral neuropathy.

Journal: European journal of pharmacology

Published: January 15, 2025

Discovery of Novel pH-Sensitive μ-Opioid Receptor Agonists as Potent Analgesics with Reduced Side Effects.

Discovery of Novel pH-Sensitive μ-Opioid Receptor Agonists as Potent Analgesics with Reduced Side Effects.

Journal: ACS medicinal chemistry letters

Published: November 01, 2024

Showing 1-12 of 33

Last Updated: 09/26/2026